Bundamedik Tbk Valuation
| BMHS Stock | 268.00 2.00 0.74% |
At this time, the firm appears to be overvalued. Bundamedik Tbk PT shows a prevailing Real Value of USD227.64 per share. The current price of the firm is USD268.0. Our model approximates the value of Bundamedik Tbk PT from analyzing the firm fundamentals such as Current Valuation of 3.68 T, profit margin of 0.06 %, and Return On Equity of 0.0811 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bundamedik Tbk's price fluctuation is very steady at this time. Calculation of the real value of Bundamedik Tbk PT is based on 3 months time horizon. Increasing Bundamedik Tbk's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Bundamedik Tbk's intrinsic value may or may not be the same as its current market price of 268.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 268.0 | Real 227.64 | Hype 268.0 | Naive 270.47 |
The intrinsic value of Bundamedik Tbk's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Bundamedik Tbk's stock price.
Estimating the potential upside or downside of Bundamedik Tbk PT helps investors to forecast how Bundamedik stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bundamedik Tbk more accurately as focusing exclusively on Bundamedik Tbk's fundamentals will not take into account other important factors: Bundamedik Tbk Total Value Analysis
Bundamedik Tbk PT is currently forecasted to have takeover price of 3.68 T with market capitalization of 3.61 T, debt of 225.96 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bundamedik Tbk fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.68 T | 3.61 T | 225.96 B |
Bundamedik Tbk Investor Information
About 79.0% of the company shares are held by company insiders. The book value of Bundamedik Tbk was currently reported as 186.41. The company recorded earning per share (EPS) of 30.71. Bundamedik Tbk PT last dividend was issued on the 1st of August 2022. Based on the analysis of Bundamedik Tbk's profitability, liquidity, and operating efficiency, Bundamedik Tbk PT is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Bundamedik Tbk Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bundamedik Tbk has an asset utilization ratio of 63.65 percent. This suggests that the Company is making USD0.64 for each dollar of assets. An increasing asset utilization means that Bundamedik Tbk PT is more efficient with each dollar of assets it utilizes for everyday operations.Bundamedik Tbk Ownership Allocation
Bundamedik Tbk holds a total of 8.6 Billion outstanding shares. Bundamedik Tbk PT shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 78.8 percent of Bundamedik Tbk PT outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bundamedik Tbk Profitability Analysis
The company reported the revenue of 1.71 T. Net Income was 215.3 B with profit before overhead, payroll, taxes, and interest of 799.78 B.About Bundamedik Tbk Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Bundamedik Tbk PT. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Bundamedik Tbk PT based exclusively on its fundamental and basic technical indicators. By analyzing Bundamedik Tbk's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Bundamedik Tbk's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bundamedik Tbk. We calculate exposure to Bundamedik Tbk's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bundamedik Tbk's related companies.8 Steps to conduct Bundamedik Tbk's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bundamedik Tbk's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bundamedik Tbk's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bundamedik Tbk's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bundamedik Tbk's revenue streams: Identify Bundamedik Tbk's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bundamedik Tbk's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bundamedik Tbk's growth potential: Evaluate Bundamedik Tbk's management, business model, and growth potential.
- Determine Bundamedik Tbk's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bundamedik Tbk's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Bundamedik Stock
Bundamedik Tbk financial ratios help investors to determine whether Bundamedik Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bundamedik with respect to the benefits of owning Bundamedik Tbk security.